Pharmaceutical Executive May 11, 2021
Launching a big pharma biotech incubator during the pandemic.
Imagine being tasked with opening a business in the past calendar year; a year that has been derailed by a global pandemic. For Sally Allain, head of Johnson & Johnson Innovation – JLABS @ Washington, DC, it hasn’t been a fictional story. Tabbed to lead Johnson & Johnson Innovation’s newest JLABS location in the nation’s capital, opening its doors this spring, Allain has earned her latest opportunity through years of hard work in the pharmaceutical industry.
Local to the D.C. area, Allain is a graduate of Virginia Tech, where she earned her BS in Microbiology as well as her MS in Microbiology and Immunology. She also holds an MBA from the...